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Abstract 
Transmembrane proteins make up critical components of living cells.  Protein function 
can be greatly impacted by the charged state of its respective components, the side chains of 
amino acid residues.  Thus far, in the lipid membrane, little is known about the properties of 
residues such as glutamic acid. To explore these properties, I have included glutamic acid in a 
suitable model peptide-lipid system for fundamental biophysical experiments.  Within the 
system, I have placed a glutamic acid residue instead of leucine in the L14 position of the helical 
hydrophobic peptide GWALP23 (acetyl-GGALWLALALALAL14ALALWLAGA-amide). 
Substitutions of glutamine and aspartic acid serve as controls for the properties of the peptide 
helix in lipid bilayer membranes. The GWALP23 peptide derivatives are placed in various lipid 
bilayer environments.  
Specifically, I investigated the impact of glutamic acid (position E14) when differently 
charged lipids are present in the bilayer. The underlying importance is to understand the charged 
or neutral state behavior of glutamic acid under conditions where it is important for the 
functioning of several types of membrane proteins, such as ion channels, drug transporters and 
others.  For the experimental plan, core alanine resides of GWALP23 were labeled with 
deuterium to enable detection of helix characteristics by solid-state 2H NMR spectroscopy. The 
peptide-lipid samples included primarily the neutral lipid DMPC, 1,2-
dimyristoylphosphatidylcholine, (with 14-carbon acyl chains), along with 10% of a charged 
lipid.  For each membrane system, I confirmed lipid bilayer formation for the particular peptide-
lipid mixture by solid-state 31P NMR. The charged lipids consisted of the negatively charged 
lipid DMPG, 1,2-dimyristoylphosphatidylglycerol, and the positively charged lipid DMTAP, 1,2-
dimyristoyl-3-trimethylammonium-propane.  These charged lipids were found to influence the 
 5 
properties of the GWALP23 helix when E14 was present.  DMTAP, in particular, improves the 
2H NMR spectra and the prospects for characterizing helix dynamics when a glutamic acid 
residue is present.  While some experiments were cut short due to a global emergency, the results 
show promise for characterizing glutamic acid in model helices and actual membrane proteins.   
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DMTAP, 1,2-dimyristoyl-3-trimethylammonium-propane 
DMPC, 1,2-dimyristoylphosphatidylcholine 
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Introduction 
 The study of transmembrane proteins is a crucial topic when investigating any aspect of 
the cell membrane. These proteins are key for maintaining proper cell function to prevent 
disease. Transmembrane proteins in the cellular lipid bilayer play major roles in the functioning 
of the cell in processes such as cell signaling, ion transport and adhesion activities1. These 
proteins make up around 30% of proteins in the cell membrane2. The structure of transmembrane 
proteins is generally made up of a stretch of hydrophobic residues, and it is speculated that the 
proteins are anchored in the membrane with aromatic residues that flank the protein by 
interacting with the charged lipid head groups3. These confer an a-helical formation in the 
hydrophobic region of the lipid bilayer membrane. Transmembrane proteins may oligomerize to 
form larger complexes of proteins, connected with a flexible loop region1,4. The polarity of 
amino acid residues present in the interior of the bilayer determine the structure and function of 
these proteins in the cell.  
 Transmembrane proteins are a significant area of biochemical research due to their roles 
in cellular function and disease. Around fifty percent of currently marketed pharmaceuticals 
target membrane proteins, due to the nature of their transport and signaling processes1. These 
targeted proteins are involved in many different diseases, including Alzheimer’s4. Some of these 
proteins require molecular chaperone, but some are able to fold into their active conformations 
based solely on their amino acid composition1. Aiming to understand the fundamental principles 
of this folding in proteins based on amino acid sequence allows the possibility of computational 
models to be built to predict the structure and function of these transmembrane proteins from the 
sequence alone, as the lipid environment greatly complicates these processes5. Along with this, 
the effect of different membrane environments must also be considered, as the cellular lipid 
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bilayer environment is made up of a variety of lipids and other materials, such as cholesterol and 
cardiolipin4.  
 In order to better understand how transmembrane proteins with certain modifications may 
interact in a cellular environment, their behavior is studied using model systems. Using a system 
of model peptides has shown to be an effective way to simplify and study isolated aspects of the 
complex protein-lipid system4. To examine the basic principles for these interactions, a synthetic 
model can be used6. Specifically, this project uses a synthetic GWALP peptide model system. 
This system was initially modified from the WALP model, containing tryptophan residues which 
function as anchors to secure the peptide in the membrane3. Characteristics of this model, such as 
its high dynamic averaging, make it a poor model to study single residue substitutions1. Further 
studies adapted the original WALP model into a GWALP23 peptide model system. This system 
has a higher stability and a defined orientation that serves to make it better suited for studying 
single residue substitutions1. Instead of containing four tryptophan residues to secure the 
transmembrane helix, this model contains two located at positions 5 and 19. The core of this 
model peptide contains repeated leucine-alanine units which create a highly hydrophobic core 
with an a-helical conformation7. This core allows the peptide to span the hydrophobic interior 
portion of the membrane, and the tryptophan residues secure the peptide in place at the polar 
exterior portions of the membrane7. This characteristic positioning allows the peptide to be 
observed using solid-state NMR spectroscopy. Different substitutions to the model can then be 
made and analyzed in comparison to examine changes in tilt and rotation within the lipid bilayer.  
In order to study this system using solid-state NMR spectroscopy, deuterium labelled 
alanine residues are utilized. A pair of these deuterated alanines are introduced at specific 
locations in the core of the GWALP23 model peptide, one in 50% and the other in 100% isotope 
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abundancy. By selecting the specific 
percent abundancies of 50% and 
100%, the residues can clearly be 
identified on 2H-NMR spectra due to 
their concentrations which present 
different peak heights upon analysis, 
as shown in Figure 1. Utilizing this 
method of analysis, previous 
experimentation has focused on analyzing the impact of substituting charged residues, such as 
arginine, histidine and glutamic acid, in different positions on the GWALP23 model peptide in 
order to study the impacts these substitutions may have on behavior in the lipid bilayer system.  
In this project, the GWALP23 model serves as a control for the system. Glutamic acid, an 
amino acid found within membrane proteins, is negatively charged in water solution at a neutral 
pH, but its ionization properties may change if glutamic 
acid is submerged in a lipid membrane. The interaction 
of this amino acid with the lipids in the cell membrane 
can therefore impact the behavior of certain 
transmembrane proteins and thereby influence cell 
function. Glutamic acid residues can be placed at various 
points in the GWALP23 model. This protein can then be 
introduced into different lipid bilayer environments to 
observe the behavior in the presence of the 
transmembrane protein. This behavior will be observed using core alanine residues labeled with 
Figure 1. 2H-NMR spectra demonstrating deuterated alanine 
residues in the core of the GWALP23-E14 peptide. These 
are present in 50% and 100% relative abundance at positions 
13 and 15. 
 
Figure 2. Models of peptide 
sequences GWALP23-E14 (glutamic 
acid) and GWALP23-Q14 
(glutamine) with highlighted 
tryptophan residues.  
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deuterium to detect helix 
characteristics by solid-state NMR 
spectroscopy. 31P-NMR spectroscopy 
will also be used in order to analyze 
the lipid bilayer orientation with the 
peptide inserted into the membrane. 
This is done to ensure that proper 
bilayers are formed. Previous studies 
with glutamic acid substitutions have focused on the study of neutral lipids. The orientation of 
the helix, with a polar residue at position 14 in GWALP23, has also been determined to be 
affected in DLPC [2].  DLPC, 1,2-dilauroyl-sn-glycero-3-phosphocholine, is a neutral lipid like 
DMPC. These experiments suggest that the pka of the E14 peptide is high or that the host helix, 
containing the E14 residue, does not respond to the titration of the side chain8. The results of this 
study with DLPC resulted in noisy spectra with poorly resolved peaks, as demonstrated in Figure 
3.  
 The objective of this project is to analyze the influence of inserting the glutamic acid 
residues and the impact of pH on the ability of the lipids to form properly oriented bilayers and 
potentially find a model similar to the cell membrane that will suit the glutamic acid side chain. 
For this project, a glutamic acid residue will be substituted at the L14 position in the helical 
model. This residue is polar and negatively charged. GWALP23-E14 will then be introduced into 
a membrane model. A list of relative peptides and their sequences is shown in Table 1.  
 
 
Figure 3. Poorly resolved 2H-NMR spectra of GWALP23-
E14 in DLPC bilayers8. 
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Peptide Sequence 
GWALP23 Ac-GGALWLALALALALALALWLAGA-amide 
GWALP23-Q14 Ac-GGALWLALALALAQALALWLAGA-amide 
GWALP23-E14 Ac-GGALWLALALALAEALALWLAGA-amide 
Table 1. Names and sequences of relevant peptides. GWALP23 was not actually synthesized but is shown in 
order to compare sequences with experimentally prepared peptides. 
 
While cellular lipid bilayers are mostly made up of neutral lipids, charged lipids are also present. 
In order to better mimic this type of environment the impact of using charged lipids will be 
studied. These will consist of the positively charged lipid, DMTAP (1,2-dimyristoyl-3-
trimethylammonium-propane), the negatively charged lipid DMPG (1,2-
dimyristoylphosphatidylglycerol), and the neutral lipid, DMPC (1,2-
dimyristoylphosphatidylcholine). The structures of these lipids are shown in Figure 4. The model 
will consist of the neutral DMPC with a percentage of the charged lipid. The results will be 
examined using solid-state 2H-NMR spectroscopy. Deuterated alanine labels will be incorporated 
into the model peptide at various positions within the core helix in order to study the effects of 
pH variation on the system. These labels will be used to determine the tilt of the helix assessed 
with solid-state 2H-NMR 
spectroscopy. This project will 
monitor changes in the quadrupolar 
splittings of the neighboring 
deuterated alanines in order to 
determine if there is a change. The 
  
DMPC 
 
 
 
DMPG 
 
 
 
DMTAP 
Figure 4. Chemical structures of lipids used in 
experimentation, DMPC, DMPG, and DMTAP. 
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outcome of this experimental analysis will be helpful in understanding various properties of 
glutamic acid containing peptides in cell membranes as well as understanding the behavior of 
glutamic acid in different lipid environments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 13 
Materials and Methods 
Solid Phase Peptide Synthesis 
The peptides of interest were synthesized using an Applied Biosystems 433A Peptide 
Synthesizer from Life Technologies9. All side chain protected amino acids were purchased from 
Novabiochem (San Diego, CA) for use in the synthesizer, with the exception of the deuterated 
alanine residues. This residue was formed and recrystallized for use in the laboratory10. For the 
peptide synthesis the Fmoc, fluorenyl methoxycarbonyl, method was used. This is a stepwise 
method where each amino acid is added individually while attached to a stabilizing resin and 
then the byproducts of the attachment reaction are removed through washing11. The amino (N) 
terminus will be capped with an acetyl group and the carboxy (C) terminus will be capped with 
an amide group. This will neutralize the charges on either end of the peptide, thus removing the 
N and C-terminus from consideration in the results of the experiment. Peptide synthesis began by 
weighing out 0.57 mmol of each amino acid required for the sequence in separate, labelled 
cartridges using an analytical balance. These cartridges were then capped. Two deuterium 
labelled alanine residues were selected to replace alanine residues in the sequence, one in 50% 
abundance and the other in 100% abundance. To measure out the 50% abundance, Fmoc-ala-d4, 
the laboratory synthesized deuterated alanine, only half of the measured 0.57 mmol of alanine 
was replaced in the cartridge with Fmoc-ala-d4. To measure out the 100% abundance, the 0.57 
mmol of alanine was entirely replaced by measured Fmoc-ala-d4. These residues were placed in 
pairs at positions 3 and 21, 13 and 15, and 9 and 11 in GWALP23-E14 and in a pair at position 
13 and 15 in GWALP23-Q14. Once properly measured out and sealed, these cartridges were 
placed in the delivery chamber of the peptide synthesizer from C-terminus to N-terminus in 
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sequence for the proper peptide. The resin was also placed into the synthesizer where the peptide 
began to form from the C-terminus. Ensuring proper synthesis is vital to spectral determination12. 
Peptide Cleavage 
 Once synthesized, the peptide must be cleaved from the stabilizing resin.  This was done 
using TFA, trifluoroacetic acid, cocktail. This cocktail is composed of an 85:5:5:5 ratio of 
TFA:TIPS:H2O:phenol11. To begin, 100 mg of peptide-resin mixture was weighed out. The TFA 
cocktail was then added to the mixture, sealed, and shaken for 3 hours. The mixture was then 
removed from the shaker and filtered through a Pasteur pipette filled with glass wool. This 
filtration effectively removed the peptide from the resin. The filtered peptide solution was then 
dried under N2 flow until a quarter of the original volume was present. Next, the peptide was 
transferred to a 50 mL centrifuge tube and precipitated from solution by adding 30 mL 
MtBE(methyl-t-butyl ether):hexane solution. The mixture was submerged in ice for 30 minutes, 
reaching a temperature of 4°C. This was then centrifuged at this temperature for 10 minutes at a 
speed of 1800 rotations per minute (RPM). After centrifugation, the supernatant was removed, 
another 30 mL of MtBE:hexane solution was added, and the previous precipitation steps repeated 
twice more. Finally, the precipitated product was dried under N2 flow, ensuring a low flow to not 
lose peptide by being blown out of the tube, 2 mL of acetonitrile added, and lyophilized, or 
freeze dried, overnight to obtain a white powder product. 
Crude Peptide Purification and Quantitation 
 The cleaved peptide product was purified using reverse-phase HPLC in order to remove 
any contaminants. The white powder product was dissolved in 0.8 mL of TFE and 0.1 mL of 
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acetic acid. This solution was filtered through a 0.22 µm yellow filter which was rinsed with 100 
µL of TFE. This ensured no particulate matter was present before purification in the HPLC, a 
Hitachi L1700 system with a Zorbax RX-C8 column (9.4 mm x 250 mm) from Agilent 
Technology. The column was rinsed overnight. A test run was performed with 10 µL of solution 
in order to determine the proper gradient for the best separation, usually a gradient of 86-90% 
methanol. Once determined, injections of 250-350 µL were performed, and the resulting product 
collected in a 50 mL centrifuge tube. This solution was dried under N2 flow. Then, 1 mL of 
acetonitrile was added, and the solution lyophilized. The process was repeated twice more and 
the final lyophilization left overnight.  
 The peptide was quantified using UV-Vis Spectroscopy and confirmed for mass and 
deuteration using MALDI-TOF mass spectrometry. The tryptophan residues in the purified 
peptide fluoresce at 280 nm, allowing the use of a diode array UV-Vis spectrophotometer to 
characterize the peptide. The lyophilized peptide was dissolved in 2 mL of TFE. The UV-Vis 
instrument was zeroed using a blank of MeOH (methanol). Then, 10 µL of peptide solution was 
mixed with 990 µL of MeOH. The cuvette was then filled with this solution and run at 280 nm. 
The optical density measured from the sample was used to calculate the amount of peptide 
present. 1.33 µL aliquots and 0.0625 µL aliquots of peptide solution were placed in separate, 
labelled glass tubes and dried under N2 flow. These were then sealed and stored in the 
refrigerator until further experimentation.  
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Circular Dichroism and Fluorescence Spectroscopy 
 0.0625 µL aliquoted peptide samples were combined with each lipid in a 1:60 ratio, dried 
under N2 flow, and placed under vacuum for 48 hours. Then, 1 mL of deuterated water was 
added, and the solution was sonicated for around 1 hour in order to form vesicles, which contain 
the peptides. The sample was centrifuged, and the supernatant collected for analysis. The 
fluorescence data of the sample was analyzed, and CD spectra recorded in order to determine if 
the peptide was a-helical in conformation.  
Oriented Sample Preparation 
 In order to perform solid-state NMR spectroscopic analysis, oriented samples were 
prepared. Peptide samples were combined with lipids in a 1:60 peptide to lipid ratio. This was 
completed by adding 80 µmol of lipid to the 1.33 µL aliquot. The lipids used for this were 
DMPC, DMPG and DMTAP. DMPC was used as a control due to its neutral nature. Charged 
samples were created by adding 5-20% of charged lipid with 80-95% DMPC. Once the lipids 
were added to the peptide and vortexed, the peptide-lipid mixture was dried under N2 flow. Two 
clean glass plates were obtained and labelled accordingly. 36 glass slides were arranged between 
the two plates. Then, 850 µL of a 1 mL solution of 47:47:6 methanol to chloroform to water was 
added to the peptide-lipid film. The mixture was then added to the slides by transferring 25 µL 
with a 50 µL Hamilton syringe to each slide, leaving two slides blank to be used as cover slides 
during hydration. The slides were allowed to dry and then placed under vacuum in a desiccator 
and shielded from light for 48 hours.  
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 After two days, the plates were removed from the vacuum line and hydrated with a buffer 
at the desired pH for experimentation. The amount of buffer required was determined by the 
molar mass of the peptide, lipids and number of slides for hydration at 45%. A 0.2-2 µL pipette 
was used to distribute the proper amount of buffer across the slides in 3 drops, while 
simultaneously stacking the plates on top of each other. Three slides maximum were hydrated at 
a time before stacking to ensure proper hydration. Using forceps, pressure was applied to the 
stack in order to mechanically create bilayers in the slides. Finally, once all plates were hydrated, 
they were placed into a cuvette for analysis and the cuvette was sealed with a glass cover and 
epoxy glue. The glue was allowed to dry, and the sample placed in a heating block at 40°C for at 
least 48 hours to incubate. Incubation ensures that the sample can acquire a liquid-crystalline 
state that allows for proper bilayer formation. Figure 5 illustrates this process.  
 
 
 
 
 
 
 
Figure 5. Visual depiction of oriented sample preparation.  
1. Peptide and lipid mixture was distributed evenly on 34 glass slides and dried under vacuum 
for 48 hours. 
2. Plates were then hydrated and stacked. 
3. The hydrated stack was placed in the cuvette & sealed. 
4. Sample was incubated at 40°C for 48 hours.  
5. NMR experiments were performed at β= 0° and 90°. 
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Solid-State 2H-NMR Spectroscopy 
Oriented samples were placed in a Bruker Avance 300 spectrometer and run twice, at 
b=0° and b=90° in respect to magnetic field. b=90°, indicates the bilayer is perpendicular to the 
magnetic field and b=0° indicates the bilayer is parallel to the magnetic field. The displayed 
spectra produce characteristic quadrupolar splittings, distance between the deuterated alanine 
peaks, that can be quantified to determine peptide orientation. These spectra were recorded and 
processed for data analysis.  
Solid-State 31P-NMR Spectroscopy 
 This method is very similar to the solid-state 2H-NMR spectroscopy. Oriented samples 
were placed in a Bruker Avance 300 spectrometer and run twice at b=0° and b=90° in respect to 
magnetic field. The displayed spectra serve to interpret if the bilayer is properly aligned by 
analyzing the phosphorous-containing head groups of the lipids. Lipid-only oriented samples 
were also analyzed with this method. These samples were prepared in the same method, omitting 
the addition of peptide.  
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Results 
In order to carry out further experimentation, the first step of analysis was to confirm the 
GWALP23-E14 peptide had been synthesized with the intended deuterium-labelled alanines 
through MALDI-TOF mass spectrometry. The expected mass of GWALP23-E14 was 2275 Da. 
The two peaks labelled in Figure 6 occur at 2302.2 and 2306.2 Da corresponding to the 50% and 
100% deuterated alanine labels, as expected for the peptide molecular mass plus a sodium ion 
plus four deuterons (50% of sample) or eight deuterons (100% of sample). In light of this, the 
method confirms the expected results.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 6. MALDI-TOF mass spectrometry isotope distribution of GWALP23-E14 
peptide. Mass to charge ratio peaks at 2302.2 and 2306.3 show peptides with 
deuterated alanines at 50% and 100%.  
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The secondary structure of GWALP23-E14 was examined using Circular Dichroism 
(CD) Spectroscopy. The hydrophobic core is expected to be a-helical in structure when inserted 
into the interior of the membrane. There is a characteristic spectral shape for this a-helical 
structure, that is in fact aligned with the spectra for GWALP23-E14 and GWALP23-Q14, which 
was used as a control, as pictured in Figure 7, with double minima at 208 nm and 222 nm13. This 
is further quantified in Table 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Circular Dichroism spectra obtained for GWALP23-E14 and GWALP23-Q14 in 10% DMPG, 10% 
DMTAP and DMPC bilayers. Two minima at 208 nm and 222 nm suggest a-helical secondary structure.  
GWALP23-E14 GWALP23-Q14 
Table 2. Numerical data for Circular Dichroism spectra of GWALP23-E14 and GWALP23-Q14 in 10% 
DMTAP, 10% DMPG and DMPC lipid bilayers. The numerical data suggests a-helical secondary 
structure. 
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 The positioning of tryptophan residues was investigated using Fluorescence Spectroscopy 
in order to analyze the fluorescence maxima in each of the bilayers. The characteristic 
wavelength expected to be observed was at or near 333 nm. Figure 8 shows these spectra 
obtained for GWALP23-E14 and GWALP23-Q14 in 10% DMTAP, 10% DMPG and DMPC 
bilayers. Table 3 details the maxima of the spectra to confirm that it is at or near 333 nm 
indicating that the tryptophan residues are situated at the lipid bilayer interface in order to anchor 
the transmembrane peptide in the lipid bilayer14.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GWALP2-E14 GWALP2-Q14 
Figure 8. Trp Fluorescence spectra for GWALP23-E14 and GWALP23-Q14 in 10% DMTAP, 10% DMPG and 
DMPC lipid bilayers. Maxima at or near 333 nm suggest that the Trp resides are situated at the lipid bilayer 
interface.  
Table 3. Numerical data for Fluorescence Maxima for GWALP23-E14 and GWALP23-Q14 in 
10% DMTAP, 10% DMPG and DMPC lipid bilayers. The maxima at or near 333 nm suggest 
the Trp residues are situated at the lipid bilayer interface.  
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31P-NMR Spectroscopy was used to 
examine the lipid bilayer alignment of the oriented 
samples in various lipid concentrations. An initial 
experiment, I did with 20% charged lipid and 80% 
neutral lipid did not form adequately oriented 
bilayers, so the focus was shifted to bilayers 
containing 10% or less charged lipid. Lipid-only 
samples as well as samples containing 
GWALP23-E14 were analyzed through this 
method, the lipid-only samples as 10% DMTAP, 
10% DMPG and DMPC and the lipid-peptide 
samples as 10% DMTAP, 10% DMPG, 5% 
DMTAP, 5% DMPG and DMPC. These were 
conducted at a pH of 6.1. The lipid-only samples 
are demonstrated in Figure 9 and the lipid-peptide 
samples in Figure 10. Each spectrum demonstrates 
proper bilayer alignment, with major well-defined 
peaks for the major DMPC component, along with 
small shoulders for the minor lipid components.   
 
 
Figure 9. 31P-NMR spectra for lipid-only samples 
at pH 6.1 for 10% DMTAP, 10% DMPG and 
DMPC.  
Figure 10. 31P-NMR spectra for lipid-peptide 
(GWALP23-E14) samples at pH 6.1 for 10% 
DMTAP, 10% DMPG, 5% DMTAP, 5% DMPG 
and DMPC. 
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 2H-NMR Spectroscopy was also used to examine the oriented samples. This data reveals 
peaks resulting from the 50% and 100% deuterium labelled alanines in the peptide that can be 
measured to determine the quadrupolar splittings. This data can be used to determine if there is a 
change in position and orientation in the lipid bilayer based on the lipids and pH variation. 
Experiments were focused on characterizing GWALP23-E14 at a pH of 6.1 with deuterium 
labels at 13 and 15 so that further work could be carried out across a range of pH levels. It was 
found that there was no change in quadrupolar splittings for all lipids, at 16.43 kHz and 6.88 
kHz, except for 10% DMPG samples, at 15.06 kHz and 5.46 kHz. The results are depicted in 
Figure 11. The spectra for these samples using DMPC bilayers showed much improvement from 
the noisy spectra obtained in previous experimentation of GWALP23-E14 in DLPC, another 
neutral lipid, shown in Figure 18.  
 
 
 
  
 
Figure 11. 2H-NMR spectra for GWALP-E14 at pH 6.1 in 10% DMTAP, 10% DMPG, 5% DMTAP, 
5% DMPG, and DMPC. No change was observed in the quadrupolar splittings measured at 16.43 kHz 
and 6.88 kHz, for all lipids except for the 10% DMPG bilayer measured at 15.06 kHz and 5.46 kHz.  
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 Additional characterization of 
GWALP23-E14 was conducted across a 
range of pH levels and analyzed using 2H-
NMR spectroscopy. Analysis of 
GWALP23-E14 with 15 and 17 deuterium 
labels and 13 and 15 deuterium labels was 
conducted. Preliminary experiments 
focused on the 15 and 17 labels at pH 5.5 
and 8.0 in 100% DMPC bilayers. A clear 
change in quadrupolar splittings was observed, as shown in Figure 12. Further experimentation 
was focused on characterizing these changes in 10% charged lipid bilayers, of DMTAP and 
DMPG, and carried out from pH 3.0 to 8.0. 
This revealed that no change was observed 
for DMPG bilayers across a range of pH, 
but there was a change in quadrupolar 
splittings, indicating titration, for DMTAP 
bilayers. This change is highlighted in 
Figure 13.  
  
 
 
 
Figure 12. 2H-NMR spectra for GWALP23-E14 
with deuterium labels at 15 and 17 at pH 5.5 and 
8.0. A change in quadrupolar splittings is 
observed. 
Figure 13. 2H-NMR spectra for GWALP23-E14 
with deuterium labels at 13 and 15 in DMTAP 
10% lipid bilayers at pH 3.0, 6.1 and 8.0. An 
observable change in quadrupolar splittings was 
demonstrated.  
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Final experiments were underway using GWALP23-E14 with deuterium labels at 3 and 
21 as well as 9 and 11, when the laboratory was shut down due to COVID-19 outbreak. These 
samples have been preserved, awaiting hydration, and analysis in solid-state 2H-NMR and 31P-
NMR spectroscopy.  
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Discussion 
 The secondary structure of GWALP23-E14 was determined to be a-helical based on 
results of Circular Dichroism (CD) spectroscopy. CD is a method of absorption spectroscopy that 
measures the difference between right and left circularly polarized light15. Different structures 
give characteristic spectral patterns. A key feature of a-helical structure is two minimum peaks 
at around 208 nm and 222 nm. These peaks were observed for the peptide of interest in all 
bilayers; therefore, the conclusion can be made that the peptide adopts an a-helical formation in 
these bilayers as expected. Additionally, the positioning of tryptophan residues was analyzed 
using fluorescence spectroscopy. The residues were confirmed to be at the peptide-lipid interface 
based on their maxima located at or near 333 nm in all bilayers. This wavelength is characteristic 
of this interface. Maxima above 333 nm indicate a more hydrophilic position, and below 333 nm 
a more hydrophobic position in the membrane16.  
Upon confirmation of these characteristics, the peptide was analyzed using 31P-NMR 
spectroscopy, to confirm bilayer alignment. The results produced confirm this alignment through 
the presentation of single, established peaks, as shown in Figures 9 and 10. With the lipid-
peptide samples containing 5% DMPG, 10% DMPG and 100% DMPC, a shoulder was 
introduced.  While a shoulder is expected from a minor component in a lipid mixture, it is not so 
clear why there is a shoulder for the 100% DMPC, unless perhaps the peptide is not distributed 
evenly within the mixture is some samples.  After this determination and results of initial 2H-
NMR spectra, all experiments were conducted using 10% of charged lipid and 90% DMPC or 
100% DMPC. This percentage was selected because experiments with 20% charged lipid did not 
form proper bilayers. Charged lipids in the amount of 10% was selected over 5% for further 
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experimentation because it more closely resembles the complex composition of cellular lipid 
bilayers which contain many charged lipids. 
 Several experiments were carried out to characterize peptide behavior in response to 
change in lipid charge, charge lipid concentration and pH variation by 2H-NMR spectroscopy. 
The resulting spectra for 10% DMTAP, 5% DMTAP, 5% DMPG and 100% DMPC showed no 
change in quadrupolar splittings based on change in charged lipid concentration and charge type. 
The splittings for these spectra were measured at peak distances of 16.4 kHz, representing 50% 
deuterated alanine at position 13 and 6.9 kHz, representing 100% deuterated alanine at position 
15. The pH in this analysis was held constant for all experiments at 6.1. Interestingly, the 10% 
DMPG spectra demonstrated a change in the peak distances with splittings measured at 15.1 
kHz, representing 50% deuterated alanine at position 13, and 5.5 kHz, representing 100% 
deuterated alanine at position 15. These changes can be attributed to changes in the helix 
orientation when DMPG is present.  
 An additional focus in the characterization of GWALP23-E14, was the determination of 
titratability of the glutamic acid side chain in the charged lipid bilayers. Glutamic acid alone, has 
a side chain pka of around 4.25 and in GWALP23-E14 the pKa has been determined to be high 
based on the effects of neighboring residues and insertion in a bilayer system. The titration 
potential of glutamic acid is the reason for a glutamine residue to be used for comparison in 
preliminary experimentation in GWALP23-Q14, as glutamine does not contain a titratable R-
group8. 2H-NMR spectra of GWALP23-E14 in DMPC only shows a change in quadrupolar 
splittings from pH 5.5 to 8.0. 2H-NMR spectra of GWALP23-E14 in 10% DMPG bilayers 
demonstrated no change in splittings and in 10% DMTAP a change was observed in splittings 
from experiments conducted in a pH range of 3.0 to 8.0. These changes indicate that the peptide 
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is titrating. More experimentation was conducted to gather spectra for pH values above 8.0 and 
below 3.0 in an effort to examine the titration curve of the peptide; however, no clearly resolved 
spectra were obtained from the initial samples.  Additional experiments will be needed.  Notably, 
it is known and documented to be difficult to prepare oriented lipid samples with peptides that 
contain glutamic acid8.   
 Final analyses of GWALP23-E14 were to be conducted through experiments at pH 6.1 in 
10% DMTAP and 10% DMPG using deuterated alanine labels at 9 and 11 as well as 3 and 21. 
These peptides were synthesized and partially prepared according to the outlined oriented sample 
preparation. The prepared samples were under vacuum for 48 hours awaiting hydration, when 
due to the outbreak of COVID-19, experimentation had to be halted as the laboratory was shut 
down. The samples were preserved for future use and are only a few days of experimentation 
away from achieving results. These results would have served to perform a GALA data analysis, 
geometric analysis of labeled alanines, in order to examine the peptide helix orientation in these 
bilayers and the end fraying of alanines 3 and 21. From such analysis, helical dynamics, tilt and 
rotation would have been able to be examined to view a full picture of peptide behavior, based 
on the quadrupolar splittings to form a quadrupolar wave plot. The plan from this point will be to 
complete this study in future work17.  
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Conclusions 
 The experiment was successful in synthesizing the proper peptide, GWALP23-E14, as 
confirmed by CD spectroscopy, Fluorescence spectroscopy and MALDI-TOF mass 
spectrometry, and successful in the analysis of the peptide in various charged lipid bilayers and 
across a range of pH values. GWALP23-E14 was confirmed to be a-helical and was verified that 
its insertion in a lipid membrane is anchored by tryptophan residues at positions 5 and 19. 
GWALP23-E14 does not show any change in behavior in response to pH variation in 10% 
DMPG but does show titratability in 10% DMTAP and 100% DMPC.  
 The peaks in the 2H NMR spectra for labeled GWALP23-E14 in DMPC are quite broad 
and poorly resolved. Inclusion of 10% DMPG alters the 2H quadrupolar splittings only slightly. 
Inclusion of 10% DMTAP notably improves the 2H spectral resolution without changing the 
quadrupolar splittings at pH 6.1.  The spectral improvement observed with DMTAP will offer 
technical advantages for future experiments.  
 It was also determined that the peptide GWALP23-E14 introduces a shoulder in the 31P 
NMR spectra of 100% DMPC and DMPG bilayers, but not when DMTAP is present. The minor 
shoulders in some of the spectra are not yet completely understood.  
 Finally, experimentation to complete a GALA analysis of peptide orientation was close to 
completion, before laboratory shutdown17. This analysis would present data about the rotation 
and tilt of the peptide in response to these variables, offering a complete view of its behavior in 
the membrane system created.  Of particular interest will be the complete results when 10% 
DMTAP is present with the peptide helix in bilayer membranes of DMPC.   
 Future work should aim to complete the characterization of this glutamic acid-containing 
peptide through a GALA analysis and investigate the use of other lipid systems in order to 
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characterize the titration of this peptide at more extreme pH levels. Additionally, an approach to 
further characterize tryptophan position in the bilayer would be to add quenchers in order to 
specifically measure the Trp depth in the membrane18. This could be performed to further 
understand peptide helix behavior, orientation in the bilayer and the influence of glutamic acid.  
The overall results will be important for understanding glutamic acid residues in membrane 
proteins.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 31 
References 
[1] Vostrikov, V. V., Hall, B. A., Greathouse D. V., Koeppe II, R. E., Sansom, M. S. P. (2010). Changes 
in Transmembrane Helix Alignment by Arginine Residues Revealed by Solid-State NMR 
Experiments and Coarse-Grained MD Simulations. Journal of American Chemical Society, 
Volume 132 (Issue 16), pages 5803-5811. 
[2] Wallin E, von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, 
archaean, and eukaryotic organisms. Protein Science : A Publication of the Protein Society. 
1998;7(4):1029-1038. 
[3] Thabado, J. K., Martfeld, A. N., Greathouse, D. V., Koeppe II, R. E., (2016). Influence of 
High pH and Cholesterol on Single Arginine-Containing Transmembrane Peptide Helices. The 
Journal of American Chemical Society: Biochemistry, Volume 55 (Issue 45), pages 6337-6343.  
[4] McKay, M. J.; Afrose, F.; Koeppe, R. E.; Greathouse, D. V. Helix Formation and Stability in 
Membranes. Biochim. Biophys. Acta - Biomembr. , No. December 2017, 1–10. 
[5] Vostrikov, V. V., Daily, A. E., Greathouse, D. V., Koeppe II, R. E. (2010). Charged or Aromatic 
Anchor Residue Dependence of Transmembrane Peptide Tilt. Journal of Biological Chemistry, 
Volume 285, pages 31723-31730. 
[6] Henderson, A. N. (2017). Influence of Histidine Residues, pH and Charge Interactions on 
Membrane-Spanning Peptides. 
[7] Schiffer, M., Chang, C. H., Stevens, F. J., (1992). The Functions of Tryptophan Residues in 
Membrane-Proteins. Protein Engineering, Volume 5 (Issue 3), pages 213-214. 
[8] Rajagopalan V, Greathouse DV, Koeppe RE. Influence of Glutamic Acid Residues and pH on the 
Properties of Transmembrane Helices. Biochimica et biophysica acta. 2017;1859(3):484-492. 
doi:10.1016/j.bbamem.2017.01.006. 
 32 
[9] Greathouse, D., Vostrikov, V., McClellan, N., Chipollini, J., Lay, J., Liyanage, R., Ladd, T., (2008). 
Lipid interactions of acylated tryptophan-methylated lactoferricin peptides by solid-state NMR. 
Journal of Peptide Science, Volume 14 (Issue 10), pages 1103-1110. 
[10] Gleason, N. J., Vostrikov, V. V., Greathouse, D. V., Grant, C. V., Opella, S. J., Koeppe II, R. E., 
(2012). Tyrosine Replacing Tryptophan as an Anchor in GWALP Peptides. The Journal of 
American Chemical Society: Biochemistry, Volume 51 (Issue 10), pages 2044-2053. 
[11] Greathouse, Denise & Goforth, Robyn & Crawford, T & Van der Wel, Patrick & Killian, 
Josephine. (2001). Optimized aminolysis conditions for cleavage of N-protected hydrophobic 
peptides from solid-phase resins. The journal of peptide research. 57. 519-27. 10.1034/j.1399-
3011.2001.00849 
[12] Vostrikov VV, Grant CV, Opella SJ, Koeppe RE. On the Combined Analysis of 2H and 15N/1H 
Solid-State NMR Data for Determination of Transmembrane Peptide Orientation and 
Dynamics. Biophysical Journal. 2011;101(12):2939-2947.  
[13] Greenfield N. J. (2006). Using circular dichroism spectra to estimate protein secondary 
structure. Nature protocols, 1(6), 2876–2890.  
[14] Ghisaidoobe, A. B., & Chung, S. J. (2014). Intrinsic tryptophan fluorescence in the detection and 
analysis of proteins: a focus on Förster resonance energy transfer techniques. International 
journal of molecular sciences, 15(12), 22518–22538. 
[15] Woody, R. W. (1985). Chapter 2- Circular Dichroism of Peptides. Conformation in Biology and 
Drug Design, 15-114.  
[16] Borkman, R. F., & Lerman, S. (1978). Fluorescence spectra of tryptophan residues in human and 
bovine lens proteins. Experimental Eye Research, 26(6), 705-713. 
 33 
[17] van der Wel, P. C. A.; Strandberg, E.; Killian, J. A.; Koeppe, R. E. Geometry and Intrinsic Tilt of a 
Tryptophan-Anchored Transmembrane Alpha-Helix Determined by 2H NMR. Biophys. J. 2002, 
83 (3), 1479–1488. 
[18] Caputo, G. A., & London, E. (2003). Using a Novel Dual Fluorescence Quenching Assay for 
Measurement of Tryptophan Depth within Lipid Bilayers to Determine Hydrophobic α-Helix 
Locations within Membranes. Biochemistry 2003, 42(11) 3265-3274. 
 
 
 
 
 
 
 
 
 
